Urinary Bladder, Neurogenic Clinical Trial
Official title:
Applying Health Mechanics to Enhance Bowel and Bladder Health for Persons With SCI
Verified date | October 2017 |
Source | University of Michigan |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This study will look at the use of a telehealth version of a self management program in
individuals with both new onset and chronic traumatic spinal cord injuries. The program is
called Health Mechanics. It is meant to enhance self management skills related to neurogenic
bladder and bowel management to prevent associated problems and improve Quality of Life
(QOL). This program is based on the needs and strengths of individuals with SCI. It focuses
on enhancing skills, encouraging positive health behaviors, empowering people within their
own environments, and recognizing that people differ in their resources and abilities. The
skills that are part of the intervention are: attitude, self-monitoring, problem-solving,
communication, organization and stress management. This study will address those skills in
the context of bladder and bowel health, with expectations that these skills to be useful in
other areas of life as well.
The investigators hypothesize that individuals in the Health Mechanics intervention group
will:
- show greater improvements in problem solving skills, healthy attitudes about disability
and knowledge of SCI management skills than will the control group
- have greater adherence to recommended bladder and bowel management behaviors than the
control group
- have fewer bladder and bowel complications than the control group
- have higher levels of QOL than the control group
In other words, this study will investigate the effectiveness of a telehealth version of
Health Mechanics to enhance self-management skills related to neurogenic bladder and bowel
management in an attempt to prevent associated complications and improve QOL.
Status | Completed |
Enrollment | 63 |
Est. completion date | February 21, 2017 |
Est. primary completion date | February 21, 2017 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria for all groups: - having a traumatic spinal cord injury - being at least 18 years old - having neurogenic bowel and/or bladder - being community-living - English-speaking Additional inclusion criteria for new injury onset groups: - completing inpatient rehabilitation for new SCI at University of Michigan Health System Additional inclusion criteria for chronic injury groups: - having an SCI for at least one year before enrollment - expressing moderate to occasional bowel and/or bladder issues on the secondary conditions scale with associated distress Exclusion Criteria for all groups: - cognitive deficits and psychiatric conditions that render persons unable to independently direct or perform their own care Additional Exclusion Criteria for chronic injury groups: - current episode of severe depression as evidenced by scoring 20 or higher on the PHQ-9 - current suicidality or suicidal ideation |
Country | Name | City | State |
---|---|---|---|
United States | University of Michigan Spinal Cord Injury Model System | Ann Arbor | Michigan |
Lead Sponsor | Collaborator |
---|---|
University of Michigan | U.S. Department of Education |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Process Evaluation | Provides an opportunity for the participant to inform the research study team on his/her experience with the intervention and assessments. | 6-month assessment | |
Primary | Spinal Cord Injury Quality of Life (SCI-QOL) Emotional Domain | The SCIQOL is administered via computerized adaptive testing forms and measures specific domains of health related quality of life relevant to living with SCI. | Change from baseline at 6-month assessment | |
Primary | SCI-QOL Physical Domain | The SCIQOL is administered via computerized adaptive testing forms and measures specific domains of health related quality of life relevant to living with SCI. | Change from baseline at 6-month assessment | |
Primary | SCI-QOL Social Domain | The SCIQOL is administered via computerized adaptive testing forms and measures specific domains of health related quality of life relevant to living with SCI. This outcome will measure between group differences. | 6-month assessment | |
Primary | Bowel and Bladder Treatment Index (BBTI) | The BBTI is a means for identification of the main method used for defecation as well as bladder management. It also measures complications and overall bowel and bladder health. | Change from baseline at 6-month assessment | |
Secondary | Adapted version of the SCI Knowledge Questionnaire - SF | Adapted from Thietje et al. (2011) this measure assesses knowledge of bladder and bowel management | Change from baseline at 6-month assessment | |
Secondary | Social Problem Solving Inventory - Revised: Short Form (SPSI-R:S) | Measures four dimensions of problem solving: negative problem orientation, rational problem solving, impulsivity/carelessness and avoidance. | Change from baseline at 6-month assessment | |
Secondary | Appraisals of Disability: Primary and Secondary Scale (ADAPSS) | Measures six dimensions of appraisal: fearful despondency, overwhelming disbelief, determined resolve, growth and resilience, negative perceptions of disability, and personal agency. | Change from baseline at 6-month assessment | |
Secondary | Disability Management Self Efficacy Scale (DMSES) - SF | Measures perceived ability to manage SCI related tasks | Change from baseline at 6-month assessment | |
Secondary | Behavioral Adherence Assessment of Bladder and Bowel Treatment (BAABBT) | The difference between prescribed (by physician) and actual behaviors related specifically to bladder and bowel methods of management | Change from baseline at 6-month assessment | |
Secondary | The Craig Handicap Assessment and Reporting Technique, Short Form (CHART-SF) | Assessment of time spent performing a variety of activities in the home and community. This outcome will measure between group differences. | 6-month assessment |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05141487 -
Feasibility of Triggered Sacral Neuromodulation for Neurogenic Bladder
|
||
Completed |
NCT04528784 -
Feasibility Study of Transcutaneous Tibial Nerve Stimulation for Urinary Symptoms in People With Multiple Sclerosis
|
N/A | |
Enrolling by invitation |
NCT03336424 -
Urinary Disorders in Patients With Multiple Sclerosis: Invasive Vs Non-invasive Investigations.
|
N/A | |
Not yet recruiting |
NCT05075642 -
Multicenter Observational Study for the Evaluation in Clinical Practice of Urinary Disorders in Multiple Sclerosis
|
||
Completed |
NCT02600715 -
Reduction of Bladder Injection Pain With Belladonna Opiate Suppository
|
Phase 4 | |
Recruiting |
NCT04128709 -
Measurement of Bladder Pressure With a Novel External Device (Cystomanometer) - Home Use
|
N/A | |
Enrolling by invitation |
NCT05740527 -
Ambulatory Closed-loop Stimulation for Bladder Control
|
N/A | |
Completed |
NCT02501928 -
Open-label Long-term Extension Study of Fesoterodine in Japanese Subjects With Neurogenic Detrusor Overactivity.
|
Phase 3 | |
Recruiting |
NCT06336304 -
NXT Post-Market Clinical Follow-up
|
||
Completed |
NCT06445426 -
Cystometry Using a Novel Microsensor System in Patients With Neurogenic Bladder Dysfunction
|
||
Recruiting |
NCT04819360 -
Botulinum Toxin A vs Anticholinergic Treatment of Neurogenic Overactive Bladder in Patients With Multiple Sclerosis
|
Phase 4 | |
Terminated |
NCT02044510 -
Urodynamic and Clinical Efficacy of Mirabegron for Neurogenic Bladder Patients
|
Phase 2/Phase 3 | |
Completed |
NCT01557244 -
A Study To Find Out How Fesoterodine Works In Children Aged 6 To 17 Years With Bladder Overactivity Caused By A Neurological Condition
|
Phase 3 | |
Recruiting |
NCT05380661 -
Heart Rate Variability and Anxiety During Urinary Bladder Catheterization
|
N/A | |
Recruiting |
NCT04193709 -
Recovery of Bladder and Sexual Function After Human Spinal Cord Injury
|
N/A | |
Completed |
NCT02582151 -
Transcutaneous Peripheral Neuromodulation for Neurogenic Bladder
|
N/A | |
Active, not recruiting |
NCT05232253 -
Cystoealstometer (Bladder Monitor Device)-Home Use
|
N/A | |
Completed |
NCT03405285 -
Connected Catheter Clinical Feasibility Study( CFS)
|
N/A | |
Completed |
NCT02673047 -
Observational Study of Botulinum Toxin Type A in Patients With Urinary Incontinence Associated With Overactive Bladder
|
N/A | |
Completed |
NCT01773213 -
Detrusor Contraction During the Ice-water-test
|
N/A |